Wyeth Expands Manufacturing Facility in Singapore

4/7/2008

Wyeth invests $96 million (SGD $134 million) to expand its existing nutritional manufacturing facility in Tuas, Singapore. The facility will produce brands of Wyeth nutritional products for infants and toddlers, including formula and milk products sold as Progress and Promise. The expansion will increase the plant's capacity by 50 percent, enabling the facility to increase its supply to the Singapore market, as well as manufacturing additional product for export to other markets throughout the Asia Pacific region. Expansion at the Tuas site is the final phase of a $500 million capital improvement project in the Asia Pacific region, which includes previously announced investments to Wyeth's global nutritional manufacturing and supply operations in China and the Philippines. Mark Larsen, president, Asia Pacific and Nutritionals, Wyeth Pharmaceuticals, says, "This investment reflects Wyeth's 90-year heritage of scientific innovation and commitment to pediatric nutrition."

Related Topics